Dow Jones is quoting sources close to Bristol-Myers Squibb who say that a buyout by Sanofi-Aventis [1] is not in the cards. BMS is betting on its pipeline [2] for its future expansion, says the source. The possibility of a tie-up has caused considerable buzz in the M&A field, especially as Sanofi-Aventis has indicated its interest in snapping up a pharma and biotech company. A deal between BMS and Sanofi looked particularly compelling because it would have expanded the French company's U.S. reach while advancing relations between two companies with a long history of collaborating on drug projects. One of those projects includes the blockbuster Plavix [3], which was the subject of a closely watched patent lawsuit and will remain under patent protection until 2011.
- check out the CNN report [4]
Related Articles:
Report: Sanofi-Aventis inks preliminary deal for BMS. Report [1]
Patent victory reignites rumors of BMS takeover. Report [5]
Rumor Mill: Is BMS going on the sales block? Report [6]
Analysts buzzing about possible Bristol-Myers sale. Report [7]
More details emerge on secret Plavix pact. Report [8]
Links:
[1] http://www.fiercebiotech.com/story/report-sanofi-aventis-inks-preliminary-deal-for-bms/2007-01-29
[2] http://www.fiercebiotech.com/special-reports/13-bristol-myers-squibb-top-15-r-d-budgets
[3] http://www.fiercepharma.com/story/bristol-profits-leap-plavix-sales/2007-10-25
[4] http://money.cnn.com/news/newsfeeds/articles/djf500/200711280920DOWJONESDJONLINE000611_FORTUNE5.htm
[5] http://www.fiercebiotech.com/story/patent-victory-reignites-rumors-of-bms-takeover/2007-06-20
[6] http://www.fiercebiotech.com/story/rumor-mill-is-bms-going-on-the-sales-block/2006-09-13
[7] http://www.fiercebiotech.com/story/analysts-buzzing-about-possible-bristol-myers-sale/2006-08-21
[8] http://www.fiercebiotech.com/story/more-details-emerge-on-secret-plavix-pact/2006-08-18